The present network with 11 academic partners and 6 non-academic partners aims to go beyond the state-of-the-art in the anti-infective field by tackling the attractive and underexplored enzymes from the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
Antimicrobial resistance is a serious global health problem and, at present, there is no collaborative inter-institutional and highly interdisciplinary consortium explicitly focused on the discovery and
development of novel anti-infective agents.
In order to achieve this ambitious goal, a group of leading scientists from academia and industry from a range of European countries has the mission to train the next generation of scientists (12 ESRs) with cutting-edge interdisciplinary skills in the discovery of new anti-infective agents.
Further details:
12 PhD Positions at MepAnti consortium